Journal of Ovarian Research

Article	Citations
Ovarian reserve in women with cystic fibrosis: is this a cause of sub-fertility?	110
CDCA5 promoted cell invasion and migration by activating TGF-β1 pathway in human ovarian cancer cells	92
Nicotinamide riboside supplementation ameliorates ovarian dysfunction in a PCOS mouse model	50
Health related quality of life and psychological parameters in different polycystic ovary syndrome phenotypes: a comparative cross-sectional study	48
Clinical characteristics and risk factors of ovarian reserve decreases in women with Crohn’s disease: a case-control study	45
Artificial oocyte activation may improve embryo quality in older patients with diminished ovarian reserve undergoing IVF-ICSI cycles	45
Trends in incidence and mortality for ovarian cancer in China from 1990 to 2019 and its forecasted levels in 30 years	44
Exploring the association of ESR1 and ESR2 gene SNPs with polycystic ovary syndrome in human females: a comprehensive association study	43
Alterations in gonadotropin, apoptotic and metabolic pathways in granulosa cells warrant superior fertility of the Dummerstorf high fertility mouse line 1	41
Retraction Note: Long non-coding RNA PTPRG-AS1 promotes cell tumorigenicity in epithelial ovarian cancer by decoying microRNA-545-3p and consequently enhancing HDAC4 expression	41
Controlled ovarian stimulation in cancer patients under 18 years old; a case series	40
Evaluation of calcification distribution by CT-based textural analysis for discrimination of immature teratoma	38
External validation of Standardized KELIM and platinum-resistant recurrence scores in patients with advanced epithelial ovarian cancer	37
Depletion of placental brain-derived neurotrophic factor (BDNF) is attributed to premature ovarian insufficiency (POI) in mice offspring	37
Evaluation of the relationship between ovarian reserve with congenital anomalies and intramural uterine leiomyoma among infertile women: a cross-sectional study	36
Up-regulation of MTHFD2 is associated with clinicopathological characteristics and poor survival in ovarian cancer, possibly by regulating MOB1A signaling	35
A real-world study of treatment patterns following disease progression in epithelial ovarian cancer patients undergoing poly-ADP-ribose polymerase inhibitor maintenance therapy	33
Risk-reducing salpingo-oophorectomy among Chinese women at increased risk of breast and ovarian cancer	31
The melatonin receptor genes are linked and associated with the risk of polycystic ovary syndrome	30
Mutations in CCNB3 affect its location thus causing a multiplicity of phenotypes in human oocytes maturation by aberrant CDK1 activity and APC/C activity at different stages	30
Can circulating cell free DNA be a promising marker in ovarian cancer? – a genome-scale profiling study in a single institution	28
Adding L-carnitine to antagonist ovarian stimulation doesn’t improve the outcomes of IVF/ ICSI cycle in patients with polycystic ovarian syndrome: a double-blind randomized clinical trial	28
Do ethnic chinese older adults with epithelial ovarian cancer survive a poorer prognosis?	27
Epitranscriptome marks detection and localization of RNA modifying proteins in mammalian ovarian follicles	27
Immune profile of primary and recurrent epithelial ovarian cancer cases indicates immune suppression, a major cause of progression and relapse of ovarian cancer	27

The role of vitamin D3 in follicle development	26
Biological and prognostic value of ETV5 in high-grade serous ovarian cancer	24
Risk-stratified CA125 screening integrating CA125 trajectories, trajectory-specific progression and transvaginal ultrasound for ovarian cancer	22
Fertility-sparing surgery in children and adolescents with borderline ovarian tumors: a retrospective study	22
Melatonin increases superoxide dismutase 2 (SOD2) levels and improves rat ovarian graft function after transplantation	22
Hexokinase 2 promoted cell motility and proliferation by activating Akt1/p-Akt1 in human ovarian cancer cells	22
Evaluation of mitochondria in mouse oocytes following cisplatin exposure	22
The efficacy and safety of angiogenesis inhibitors for recurrent ovarian cancer: a meta‑analysis	22
Anastomotic leakage after resection of the rectosigmoid colon in primary ovarian cancer	21
Baicalein improves the chemoresistance of ovarian cancer through regulation of CirSLC7A6	20
Single-cell RNA sequencing of human oocytes reveals a differential transcriptomic profile associated with agar-like zona pellucida	20
The synergistic mechanisms of propofol with cisplatin or doxorubicin in human ovarian cancer cells	20
Genetic determination of the ovarian reserve: a literature review	20
CircCDK17 knockdown inhibits tumor progression and cell glycolysis by downregulaing YWHAZ expression through sponging miR-1294 in cervical cancer	20
Luteinizing hormone stimulates the expression of amphiregulin in human theca cells	19
Potential use of DNA methylation in cervical swabs for early ovarian cancer diagnosis	19
Expression of long noncoding RNAs in the ovarian granulosa cells of women with diminished ovarian reserve using high-throughput sequencing	19
Exploring the causal associations of the gut microbiota and plasma metabolites with ovarian cancer: an approach of mendelian randomization analysis combined with network pharmacology and molecular doc	19
Evolutionary perspectives, heterogeneity and ovarian cancer: a complicated tale from past to present	19
B4GALT5 a sialylation-related genes associated with patient prognosis and immune microenvironment in ovarian cancer and pan-cancer	18
Next-generation sequencing of 500 POI patients identified novel responsible monogenic and oligogenic variants	18
Amplifications of EVX2 and HOXD9-HOXD13 on 2q31 in mature cystic teratomas of the ovary identified by array comparative genomic hybridization may explain teratoma characteristics in chondrogenesis and	18
Meta-analysis of trigger timing in normal responders undergoing GnRH antagonist ovarian hyperstimulation protocol	18
Development and clinical validation of a seven-gene signature based on tumor stem cell-related genes to predict ovarian cancer prognosis	18
Cardiovascular mortality risk in patients with ovarian cancer: a population-based study	18
Two-dimensional and three-dimensional T2 weighted imaging-based radiomic signatures for the preoperative discrimination of ovarian borderline tumors and malignant tumors	18
Uterine involvement in epithelial ovarian cancer and its risk factors	18
Aged mice ovaries harbor stem cells and germ cell nests but fail to form follicles	17
The mechanisms of MicroRNA 21 in premature ovarian insufficiency mice with mesenchymal stem cells transplantation	17
Prognostic significance and risk factors for pelvic and para-aortic lymph node metastasis in type I and type II ovarian cancer: a large population-based database analysis	17
HOXB2 promotes cisplatin resistance by upregulating lncRNA DANCR in ovarian cancer	17
Protective effect of Luffa cylindrica fermentation liquid on cyclophosphamide-induced premature ovarian failure in female mice by attenuating oxidative stress, inflammation and apoptosis	17
Causal association between low vitamin D and polycystic ovary syndrome: a bidirectional mendelian randomization study	17
Exosomes in diagnostic and therapeutic applications of ovarian cancer	16
Correction: Metformin modifies plasma microbial-derived extracellular vesicles in polycystic ovary syndrome with insulin resistance	16
The diagnostic performance of CA-125 for the detection of ovarian cancer in women from different ethnic groups: a cohort study of English primary care data	16
Trophectoderm biopsy of blastocysts for a preimplantation genetic test does not affect serum β-hCG levels in early pregnancy: a study using propensity score matching	15
Subtype-specific analysis of gene co-expression networks and immune cell profiling reveals high grade serous ovarian cancer subtype linkage to variable immune microenvironment	15
Plasma-derived exosomal miR-4732-5p is a promising noninvasive diagnostic biomarker for epithelial ovarian cancer	15
Ovarian sex cord stromal tumours: analysis of the clinical and sonographic characteristics of different histopathologic subtypes	15
MiR-585-3p suppresses tumor proliferation and migration by directly targeting CAPN9 in high grade serous ovarian cancer	14
Mitigation of letrozole induced polycystic ovarian syndrome associated inflammatory response and endocrinal dysfunction by Vitex negundo seeds	14
KAS-seq profiling captures transcription dynamics during oocyte maturation	14
COVID-19 in Africa: an ovarian victory?	14
Can expelled cells/debris from a developing embryo be used for PGT?	14
LncRNA RBAT1 reduces chemosensitivity of cancer cells to carboplatin/paclitaxel by sponging miR‑27b in endometrial carcinoma	14
Long non-coding RNA OIP5-AS1 suppresses microRNA-92a to augment proliferation and metastasis of ovarian cancer cells through upregulating ITGA6	14
PARP inhibitor era in ovarian cancer treatment: a systematic review and meta-analysis of randomized controlled trials	14
The enhancer RNA ADCY10P1 is associated with the progression of ovarian cancer	14
Differences between complex epithelial neoplasms of the ovary and high-grade serous ovarian cancer: a retrospective observational cohort study	14

Prohibitin 1 interacts with p53 in the regulation of mitochondrial dynamics and chemoresistance in gynecologic cancers	14
Maintenance therapy for newly diagnosed epithelial ovarian cancer– a review	13
Association between cytokines and progression-free survival in ovarian cancer following CRS/HIPEC treatment	13
Molecular response to PARP1 inhibition in ovarian cancer cells as determined by mass spectrometry based proteomics	13
Causal relationship between inflammatory cytokines and polycystic ovary syndrome: a bidirectional mendelian randomization study	13
In-vivo oogenesis of oogonial and mesenchymal stem cells seeded in transplanted ovarian extracellular matrix	13
CXCL2-mediated ATR/CHK1 signaling pathway and platinum resistance in epithelial ovarian cancer	13
A preliminary study on the effects of Xiang Shao granules on reproductive endocrinology in drugged ovariectomised rats	13
Targeted proteomics of plasma extracellular vesicles uncovers MUC1 as combinatorial biomarker for the early detection of high-grade serous ovarian cancer	13
Ovarian inguinal hernia – a possibility in MURCS syndrome	13
Bevacizumab confers significant improvements in survival for ovarian cancer patients with low miR-25 expression and high miR-142 expression	12
The role of oxidative stress in ovarian aging: a review	12
Circular RNA circ-BNC2 (hsa_circ_0008732) inhibits the progression of ovarian cancer through microRNA-223-3p/ FBXW7 axis	12
High expression level of miR-1260 family in the peripheral blood of patients with ovarian carcinoma	12
Long noncoding RNA SNHG25 promotes the malignancy of endometrial cancer by sponging microRNA-497-5p and increasing FASN expression	12
Knowledge and attitudes towards clinical trials among women with ovarian cancer: results of the ACTO study	12
Proteomic analysis implicates that postovulatory aging leads to aberrant gene expression, biosynthesis, RNA metabolism and cell cycle in mouse oocytes	12
LncRNA DLEU1 is overexpressed in premature ovarian failure and sponges miR-146b-5p to increase granulosa cell apoptosis	12
Ovarian tissue cryopreservation in a patient with breast cancer during pregnancy: a case report	12
Ginseng alleviates folliculogenesis disorders via induction of cell proliferation and downregulation of apoptotic markers in nicotine-treated mice	12
Comparison of oocyte vitrification using a semi-automated or a manual closed system in human siblings: survival and transcriptomic analyses	11
LH level on ovulation trigger day has a different impact on the outcomes of agonist and antagonist regimens during in vitro fertilization	11
The presence of ovarian endometrioma adversely affect ovarian reserve and response to stimulation but not oocyte quality or IVF/ICSI outcomes: a retrospective cohort study	11
Development of a necroptosis-related gene signature and the immune landscape in ovarian cancer	11
Effects of n-3 PUFA supplementation on oocyte in vitro maturation in mice with polycystic ovary syndrome	11
Pretreatment with a long-acting GnRH agonist for frozen-thawed embryo transfer cycles: how to improve live birth?	11
The prolactin receptor gene (PRLR) is linked and associated with the risk of polycystic ovarian syndrome	11
Clinical application of PARP inhibitors in ovarian cancer: from molecular mechanisms to the current status	11
An EMT-based gene signature enhances the clinical understanding and prognostic prediction of patients with ovarian cancers	11
Effects of vitrified cryopreservation duration on IVF and neonatal outcomes	11
Serum and follicular fluid levels of soluble receptor for advanced glycation end-products in women with and without polycystic ovary syndrome	11
Integrated fecal microbiota and metabolomics analysis of the orlistat intervention effect on polycystic ovary syndrome rats induced by letrozole combined with a high-fat diet	11
Multi-omics reveal the metabolic patterns in mouse cumulus cells during oocyte maturation	11
Factors affecting cumulative live birth rate after the 1st oocyte retrieved in polycystic ovary syndrome patients in women during IVF/ICSI-ET	11
Molecular mechanism of Wilms’ tumor (Wt1) (+/−KTS) variants promoting proliferation and migration of ovarian epithelial cells by bioinformatics analysis	11
The serum oestradiol/progesterone ratio on the day of OPU + 7, but not the day of OPU + 5, affects the rates of live birth in fresh blastocyst embryo transfer cycles	11
Ovarian absence: a systematic literature review and case series report	11
Retraction Note: CYPA promotes the progression and metastasis of serous ovarian cancer (SOC) in vitro and in vivo	11
Dehydroepiandrosterone supplementation and the impact of follicular fluid metabolome and cytokinome profiles in poor ovarian responders	11
Cut-off point of mature oocyte for routine clinical application of rescue IVM: a retrospective cohort study	11
Identification of upregulated exosomal miRNAs between A2780 and A2780/DDP human ovarian cancer cells by high-throughput sequencing	11
Correction: In vitro drug testing using patient-derived ovarian cancer organoids	10
Comprehensive in silico analysis of prognostic and immune infiltrates for FGFs in human ovarian cancer	10
Retrospective analysis of GnRH-a prolonged protocol for in vitro fertilization in 18,272 cycles in China	10
Efficacy and safety of Shen Que (RN8) moxibustion on reproductive outcomes in unexpected poor ovarian responders: a randomized controlled trial	10
A novel heterozygous missense variant of PANX1 causes human oocyte death and female infertility	10
ErZhiTianGui Decoction alleviates age-related ovarian aging by regulating mitochondrial homeostasis and inhibiting ferroptosis	10
Novel variants in TUBB8 gene cause multiple phenotypic abnormalities in human oocytes and early embryos	10
Correction: TP63 truncating mutation causes increased cell apoptosis and premature ovarian insufficiency by enhanced transcriptional activation of CLCA2	10
Interaction of lncRNA Gm2044 and EEF2 promotes estradiol synthesis in ovarian follicular granulosa cells	10
Knockdown of heat shock protein family D member 1 (HSPD1) promotes proliferation and migration of ovarian cancer cells via disrupting the stability of mitochondrial 3-oxoacyl-ACP synthase (OXSM)	10
Nur77 ameliorates cyclophosphamide-induced ovarian insufficiency in mice by inhibiting oxidative damage and cell senescence	10
Correction: Bone marrow mesenchymal stem cells expressing Neat-1, Hotair-1, miR-21, miR-644, and miR-144 subsided cyclophosphamide-induced ovarian insufficiency by remodeling the IGF-1–kisspeptin syst	10
The possible short-term of Nigella sativa – L in the management of adolescent polycystic ovarian syndrome: results of a randomized controlled trial	10
Maternal and perinatal risks for monozygotic twins conceived following frozen-thawed embryo transfer: a retrospective cohort study	10
The impact of oral isotretinoin on ovarian functions of acne patients complaining of polycystic ovarian syndrome: a prospective study	10
Correction: Alteration of the N6‑methyladenosine methylation landscape in a mouse model of polycystic ovary syndrome	10
Targeting TMEM205 mediated drug resistance in ovarian clear cell carcinoma using oncolytic virus	10
Correction: H3K27ac-induced lncRNA PAXIP1-AS1 promotes cell proliferation, migration, EMT and apoptosis in ovarian cancer by targeting miR-6744-5p/PCBP2 axis	10
Placental mesenchymal stem cells ameliorate NLRP3 inflammasome-induced ovarian insufficiency by modulating macrophage M2 polarization	10
An unusual association of type II Mayer-Rokitansky-Kuster-Hauser syndrome, turner mosaic syndrome and tubo-ovarian inguinal hernia– case report and review of literature	10
Pre-operative plasma VEGF-C levels portend recurrence in epithelial ovarian cancer patients and is a bankable prognostic marker even in the initial assessment of a patient	10
Exploration and prognostic analysis of two types of high-risk ovarian cancers: clear cell vs. serous carcinoma: a population-based study	10
Yu Linzhu alleviates primary ovarian insufficiency in a rat model by improving proliferation and energy metabolism of granulosa cells through hif1α/cx43 pathway	10
BRCA1 and BRCA2 deficient tumour models generate distinct ovarian tumour microenvironments and differential responses to therapy	10
Exploring the causal role of multiple metabolites on ovarian cancer: a two sample Mendelian randomization study	10
Differences of survival benefits brought by various treatments in ovarian cancer patients with different tumor stages	10
Identification and validation of a gene-based signature reveals SLC25A10 as a novel prognostic indicator for patients with ovarian cancer	9
Changes in peripheral lymphocyte populations in patients with advanced/recurrent ovarian cancer undergoing splenectomy during cytoreductive surgery	9
Metastatic colorectal cancer as the primary phenotype in a hereditary breast and ovarian cancer patient with Germline BRCA1 mutation: a case report	9
MicroRNAs as the critical regulators of Cisplatin resistance in ovarian cancer cells	9
MiR-149-3p promotes the cisplatin resistance and EMT in ovarian cancer through downregulating TIMP2 and CDKN1A	9
Combined analysis of estradiol and β-hCG to predict the early pregnancy outcome of FET: a retrospective study	9
The experıance of tertıary center for adult granulosa cell tumor: whıch factors predıct survival?	9
Analysis of prognostic value of lactate metabolism-related genes in ovarian cancer based on bioinformatics	9
The stromal microenvironment and ovarian aging: mechanisms and therapeutic opportunities	9
Knockdown of ENTPD5 inhibits tumor metastasis and growth via regulating the GRP78/p-eIF-2α/CHOP pathway in serous ovarian cancer	9
Efficacy of three COS protocols and predictability of AMH and AFC in women with discordant ovarian reserve markers: a retrospective study on 19,239 patients	9
Bone marrow mesenchymal stem cells expressing Neat-1, Hotair-1, miR-21, miR-644, and miR-144 subsided cyclophosphamide-induced ovarian insufficiency by remodeling the IGF-1–kisspeptin system, ovarian	9
Targeting purine metabolism in ovarian cancer	9

Searching for the ‘X’ factor: investigating the genetics of primary ovarian insufficiency	9
Correlation between ovarian follicular development and Hippo pathway in polycystic ovary syndrome	9
Preparation of triangular silver nanoparticles and their biological effects in the treatment of ovarian cancer	9
LCK facilitates DNA damage repair by stabilizing RAD51 and BRCA1 in the nucleus of chemoresistant ovarian cancer	9
Retraction Note: H3K27ac-induced lncRNA PAXIP1-AS1 promotes cell proliferation, migration, EMT and apoptosis in ovarian cancer by targeting miR-6744-5p/PCBP2 axis	9
Integrated analysis of single-cell RNA-seq and bulk RNA-seq unveils heterogeneity and establishes a novel signature for prognosis and tumor immune microenvironment in ovarian cancer	9
Prognostic analysis of peritoneal washing cytology during interval debulking surgery in advanced ovarian cancer	9
The impact of Paclitaxel-based hyperthermic intraperitoneal chemotherapy in advanced high-grade serous ovarian cancer patients - interim analysis of safety and immediate efficacy of a randomized contr	9
Targeting mitochondrial metabolism with CPI-613 in chemoresistant ovarian tumors	9
Integrative analysis of key candidate genes and signaling pathways in ovarian cancer by bioinformatics	9
A bioinformatics analysis: ZFHX4 is associated with metastasis and poor survival in ovarian cancer	9
Circular RNA hsa_circ_0000144 aggravates ovarian Cancer progression by regulating ELK3 via sponging miR-610	9
Mechanisms of He Shi Yu Lin formula in treating premature ovarian insufficiency: insights from network pharmacology and animal experiments	9
Effect of melatonin supplementation on cardiometabolic risk factors, oxidative stress and hormonal profile in PCOS patients: a systematic review and meta-analysis of randomized clinical trials	9
Knockdown of circ-FURIN suppresses the proliferation and induces apoptosis of granular cells in polycystic ovary syndrome via miR-195-5p/BCL2 axis	9
A mouse model of neoadjuvant chemotherapy followed by interval cytoreductive surgery indicates impaired efficacy of perioperative cisplatin	8
Structural organization of the neuronal pathways of the superior ovarian nerve in the rat	8
A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer	8
Plasma circRNA microarray profiling identifies novel circRNA biomarkers for the diagnosis of ovarian cancer	8
Integrated clinical characteristics and omics analysis identifies a ferroptosis and iron-metabolism-related lncRNA signature for predicting prognosis and therapeutic responses in ovarian cancer	8
The impact of blastomere loss on pregnancy and neonatal outcomes of vitrified-warmed Day3 embryos in single embryo transfer cycles	8
Differentially expression and function of circular RNAs in ovarian cancer stem cells	8
Pro-cancerogenic effects of spontaneous and drug-induced senescence of ovarian cancer cells in vitro and in vivo: a comparative analysis	8
Personalization of IVF-ICSI workflow based on patient characteristics improves IVF laboratory outcomes and embryo ploidy by PGT-A	8
Synaptotagmin-like protein 1 is a potential diagnostic and prognostic biomarker in endometrial cancer based on bioinformatics and experiments	8
High expression of RIPK2 is associated with Taxol resistance in serous ovarian cancer	8
BDNF promotes mouse follicular development and reverses ovarian aging by promoting cell proliferation	8
Fisetin-induced cell death in human ovarian cancer cell lines via zbp1-mediated necroptosis	8
Characteristics and outcomes analysis of ovarian Sertoli–Leydig cell tumors (SLCTs): analysis of 15 patients	8
Serum CCAT2 as a biomarker for adjuvant diagnosis and prognostic prediction of cervical cancer	8
LncRNA DANCR counteracts premature ovarian insufficiency by regulating the senescence process of granulosa cells through stabilizing the interaction between p53 and hNRNPC	8
UBE2T regulates epithelial–mesenchymal transition through the PI3K-AKT pathway and plays a carcinogenic role in ovarian cancer	8
Toxic effect window of ovarian development in female offspring mice induced by prenatal prednisone exposure with different doses and time	8
Wip1 suppresses angiogenesis through the STAT3-VEGF signalling pathway in serous ovarian cancer	8
Correction: Polycystic ovary rat model exposure to 150 kHz intermediate frequency: hypothalamic-pituitary-ovarian axis at the receptor, cellular, tissue, and hormone levels	8
LncRNA SNHG20 promotes migration and invasion of ovarian cancer via modulating the microRNA-148a/ROCK1 axis	8
Cocultured porcine granulosa cells respond to excess non-esterified fatty acids during in vitro maturation	8
Detection of plasma exosomal miRNA-205 as a biomarker for early diagnosis and an adjuvant indicator of ovarian cancer staging	8
Lifetime ovulatory years and ovarian cancer gene expression profiles	8
Alterations of bacteriome, mycobiome and metabolome characteristics in PCOS patients with normal/overweight individuals	8
A novel defined programmed cell death related gene signature for predicting the prognosis of serous ovarian cancer	7
Folliculogenesis and steroidogenesis alterations after chronic exposure to a human-relevant mixture of environmental toxicants spare the ovarian reserve in the rabbit model	7
MiR-134-3p targets HMOX1 to inhibit ferroptosis in granulosa cells of sheep follicles	7
Management of advanced ovarian cancer in Spain: an expert Delphi consensus	7
Aneuploid serves as a prognostic marker and favors immunosuppressive microenvironment in ovarian cancer	7
Sestrin1, 2, and 3 are dispensable for female fertility in mice	7
Dose inhibin B or anti-Müllerian hormone relate to precocious puberty in girls? result of a systematic review and meta-analysis	7
Dehydroepiandrosterone-induced polycystic ovary syndrome mouse model requires continous treatments to maintain reproductive phenotypes	7
Sialyl-Tn serves as a potential therapeutic target for ovarian cancer	7
Implication of vasopressin receptor genes (AVPR1A and AVPR1B) in the susceptibility to polycystic ovary syndrome	7
Examining the oleoylethanolamide supplement effects on glycemic status, oxidative stress, inflammation, and anti-mullerian hormone in polycystic ovary syndrome	7
LncRNA TMPO-AS1 suppresses the maturation of miR-335-5p to participate in polycystic ovary syndrome	7
Molecular and biological functions of gingerol as a natural effective therapeutic drug for cervical cancer	7
Premature ovarian insufficiency: a review on the role of tobacco smoke, its clinical harm, and treatment	7
Do we overlook predictive factors in Poseidon 1 patients? A retrospective analysis co-evaluating antral follicle counts & diameters	7
The effect of paclitaxel- and fisetin-loaded PBM nanoparticles on apoptosis and reversal of drug resistance gene ABCG2 in ovarian cancer	7
Prognostic marker C3AR1 is associated with ovarian cancer cell proliferation and immunosuppression in the tumor microenvironment	7
Progestin and adipoQ receptor 7 (PAQR7) mediate the anti-apoptotic effect of P4 on human granulosa cells and its deficiency reduces ovarian function in female mice	7
ADC: a deadly killer of platinum resistant ovarian cancer	7
Stem cell-based therapeutic potential in female ovarian aging and infertility	7
ERCC1 rs11615 polymorphism and chemosensitivity to platinum drugs in patients with ovarian cancer: a systematic review and meta-analysis	7
In vitro matured oocytes have a higher developmental potential than in vivo matured oocytes after hormonal ovarian stimulation in Callithrix jacchus	7
Investigation of androgen receptor CAG repeats length in polycystic ovary syndrome diagnosed using the new international evidence-based guideline	7
No evidence for a diminished ovarian reserve among patients with hypertensive disorders of pregnancy: a case control study	7
The PAPSS1 gene is a modulator of response to cisplatin by regulating estrogen receptor alpha signaling activity in ovarian cancer cells	7
Proteomic analysis of exosomes secreted during the epithelial-mesenchymal transition and potential biomarkers of mesenchymal high-grade serous ovarian carcinoma	7